Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple 5-Step nursing plan could slash deadly clot risk after hip surgery

NCT ID NCT07702903

Disease control Sponsor: Murat Erten Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether a structured 5-part nursing care bundle can reduce dangerous blood clots (venous thromboembolism) after total hip replacement surgery. The bundle includes patient education, ankle exercises, early walking, fluid management, and compression stockings. About 110 adults who had hip replacement will receive either this bundle or standard care, and researchers will track clot rates, leg swelling, comfort, and satisfaction for 90 days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a 5-part nursing care bundle including education, ankle exercises, early mobilization, fluid management, and compression stockings
What this could lead to
If effective, this care bundle could become a standard, low-cost way to reduce life-threatening blood clots after hip replacement surgery.
What could go wrong
This is a small, non-randomized study, so results may be less reliable. The bundle requires consistent nursing effort, and its benefits over standard care are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 110 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 years and older. * Scheduled for elective primary total hip replacement surgery. * Conscious, oriented, and able to communicate effectively to complete questionnaires and understand education. * Volunteering to participate in the study and able to provide written informed consent. * Physically capable of participating in early mobilization and bed exercises postoperatively. Exclusion Criteria: * Previous history of Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE). * Known bleeding disorders or coagulation abnormalities (e.g., thrombophilia). * Contraindications to the use of mechanical prophylaxis/compression stockings (e.g., severe peripheral arterial disease, severe skin lesions, or leg ulcers). * Severe cognitive impairment, dementia, or psychiatric disorders that prevent cooperation with the study protocol and care bundle. * Bedridden prior to surgery or having severe neurological/musculoskeletal conditions completely preventing mobilization.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Deep vein thrombosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Venous Thrombosis venous thromboembolism prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Deep vein thrombosis Total hip arthroplasty (THA) Venous thromboembolism

Contacts and locations

Locations

  • Mardin Training and Research Hospital, Kızıltepe State Hospital

    Mardin, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.